Gut bacteria could help make cancer therapies more effective. The international METRICs project, led by TU Dresden, is exploring this with around €2 million in funding and partners across three continents. | more
Around 90 percent of all cancers are so-called solid tumors – growths that form dense tissue. Many of them remain difficult to treat. Researchers at TU Dresden have genetically modified immune cells so that they can penetrate deep into tumor tissue and potentially attack cancer cells over the long term. The EU is now funding the project with 2.5 million euros. | more
